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Abstract
Purpose To develop an evidence-based decision aid for parents of children with cancer and to help guide them in the use of
complementary and alternative medicine (CAM) for cancer care.
Methods This study had a mixed research design. The needs of parents were investigated by survey and focus group. A
systematic review and meta-analysis were performed on the effectiveness of CAM using Grading of Recommendations
Assessment, Development and Evaluation (GRADE). Clinical experts were interviewed and a decision aid on CAM treatment
for pain was developed.
Results Parents emphasized the importance of reliable information on CAM, focusing primarily on communication and a broad
spectrum of complaints related to cancer treatment. The decision aid on CAM for pain included five modalities based on 11
randomized control trials (RCTs): hypnotherapy, mind-body techniques, massage, healing touch, and music therapy. Meta-
analysis could be performed on hypnotherapy, which significantly reduced cancer-related procedural pain compared with
standard care (MD, − 1.37; 95% CI, − 1.60, − 1.15; P < 0.00001) and attention control (MD, − 1.13; 95% CI, − 1.34, − 0.94;
P < 0.00001), and massage, demonstrating no effect on pain compared with standard care (MD, − 0.77; 95% CI, − 1.82, 0.28;
P = 0.15). Research evidence and supplementary information from clinical practice and patient were incorporated in a website-
based decision aid.
Conclusions An evidence-based decision aid was developed to support parents of children with cancer in making decisions about
CAM for pain management. Next steps will be to expand the website to include additional childhood cancer-related complaints
and to evaluate its use in practice.
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Introduction
Complementary and alternative medicine (CAM) can be de-
fined as healthcare approaches that are not typically part of
conventional medical care or that may have origins outside of
usual Western practice [1]. Although not part of mainstream
medicine, an increasing number of children with cancer use
CAM along with conventional therapies [2]. Parents choose
CAM for treatment and cure of cancer in their children [3],
and also as supportive care agent to help minimize side effects
of cancer treatment and to improve the general quality of life
and well-being [4, 5]. The prevalence of CAM use among
children with cancer is high and varies between 6 and 100%,
depending on the survey sample and country, and is on aver-
age 47.2% in high-income countries [3]. CAM modalities
most commonly used are herbs, diets and nutrition, homeop-
athy, and prayer [4, 6, 7]. Despite the high prevalence of CAM
use in children with cancer, it is difficult for parents to find
reliable information about it. Existing platforms developed to
advise patients on CAM use for cancer, for example the
website of the National Cancer Institute [8], are directed to-
wards cancer in adults and do not specifically discuss the
suitability of CAMmodalities for use in children. Other infor-
mation available on the internet is of poor quality [9] and
frequently includes the statement: “Always consult with your
child’s physician before beginning any CAM, because some
therapies may interfere with standard treatment.” However,
physicians typically do not receive training in CAM and have
limited knowledge on the subject and so find themselves un-
able to discuss any possible (side) effects of CAM [10, 11].
Additionally, it is known that few parents even discuss CAM
use with the pediatric oncologist [7, 12, 13]. Authoritative and
reliable access to information is thus needed to support parents
in their search for information on CAMmodalities as potential
supportive treatment options for their children with cancer.
This study describes the process and outcome of a project
that aimed to develop and implement an evidence-based deci-
sion aid on CAM use for pain in order to enable parents of
children with cancer to make well-informed decisions
concerning CAM. Since children with cancer use CAM most
often as supportive care agent [14, 15], the decision aid fo-
cused on supportive CAM care for pain.
Methods
Project design
The project had four phases of mixed methodology design
(see Fig. 1) and was carried out from 2014 to 2017 by a
multidisciplinary team of pediatric oncologists, members of
the patient organization for parents of children with cancer
(VOKK), CAM experts, and researchers. A scientific advisory
board consisting of six pediatricians/pediatric oncologists sup-
ported the project team.
Phase 1: needs of parents
The needs of parents with respect to a decision aid on CAM
use for their children with cancer were investigated by means
of a survey and focus group.
Survey In April–May 2015, a 23-item anonymous question-
naire was distributed by the VOKK to parents of children with
cancer via their e-newsletter and Facebook campaign. The
questionnaire was modified from previously used question-
naires on self-management instruments [16] and CAM [7,
17]. It was validated through a pilot survey among eight par-
ents and revised accordingly with respect to rewording terms
to prevent misinterpretation. The questionnaire is attached as
online resource 1. Descriptive statistics were used to analyze
the data by means of SPSS 22.0.
Focus group A focus group took place in June 2015 with
seven parents of children with cancer that were recruited by
the VOKK. The first part of the focus group used the
brainwriting technique [18] in response to the following ques-
tion: What do you need in order to make a good choice about
CAM use for your child? Next, the following topics were
discussed: possible reasons to use CAM, information and
decision-making on CAM use, communication about CAM
with physicians/oncologists, and any additional requirements
for a decision aid on CAM. The focus group lasted 2 h and
was recorded, and field notes were taken. A directive content
analysis [19] was performed to get a better understanding of
the parents’ needs regarding a decision aid on CAM.
Phase 2: evidence on CAM
Evidence for CAMwas investigated by means of a systematic
review and meta-analyses. It was limited to pain management
in children as it was not feasible within the project grant and
time to perform additional systematic reviews on other cancer-
related complaints.
Systematic review and meta-analysis The review was planned
and conducted in accordance with the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines [20]. The protocol was not registered
in a database. The PICOS (Patient-Intervention-Comparison-
Outcome-Study) design for the systematic reviewwas defined
as follows: Effects (reduction) on experienced pain during
cancer treatment and post-treatment and occurrence of adverse
events (outcome) of CAM (intervention) in comparison with
no treatment, standard treatment, and placebo control or active
control group (comparison) in children with cancer (patient)
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reported in prospective controlled studies (study). Between
December 2015 and March 2016, the PubMed, EMBASE,
Cochrane, and CINAHL were searched. Search terms and
strings are attached as online resource 2. Inclusion criteria
were peer-reviewed prospective controlled studies in children
(0–18 years) with any type of cancer undergoing a CAM
intervention (as defined by the National Center for
Complementary and Alternative Medicine [21]) published in
English or Dutch language. The primary outcome was pain
(any pain-related outcome), and the secondary outcome was
reported CAM-related adverse events. Two researchers per-
formed the selection of studies, data extraction, and risk of
bias assessments. Any instances of disagreement were re-
solved by consultation with a third researcher. The risk of bias
assessment was done according to the Grading of
Recommendations Assessment, Development and
Evaluation (GRADE) handbook [22]. The GRADE approach
was used to facilitate the overall quality of each outcome and
to assess risk of bias across studies [23]. Meta-analysis was
performed in cases where the results of two or more random-
ized clinical trials (RCTs) per CAMmodality could be pooled
using RevMan 5.3 (Cochrane collaboration) and GRADEpro
(version 3.6) for different scores related to pain across inter-
ventions. I2 was used to test for heterogeneity in judging con-
sistency of evidence.
Clinical experience Six pediatric oncologists working at inte-
grative pediatric oncology clinics in Canada, the USA,
Germany, and Italy were interviewed to collect information
related to the use and safety of CAM in the treatment of pain
in children with cancer. These experts were identified at the
International Congress on Integrative Medicine and Health
(Las Vegas, 2016). The interview guide consisted of seven
questions (see online resource 3). Interviews were conducted
face-to-face or via Skype, were recorded, and varied in length
from 30 to 60 min. The content was analyzed and categorized
as follows: CAM modalities, effects, treatment phase, type of
pain and patient, complaints, and side effects.
Phase 3: development decision aid
The objective of phase 3 was to combine information on re-
search evidence and clinical expertise in order to inform rec-
ommendations and decision-making regarding CAM use for
pain management in children with cancer. A 3-h expert meet-
ing was organized in June 2016 consisting of a balanced mix
of pediatric oncologists, pediatricians, pediatric nurses, par-
ents, CAM experts, researchers, and members of the patient
organization. The meeting included 14 participants in total.
Preceding the expert meeting, all participants read the out-
come and underlying documentation of phase 2 and were
informed about the procedure and steps in the meeting, which
followed the seven-step approach of GRADE [22]. Other
CAM-related contextual factors taken into consideration in-
cluded whether the CAM treatment was safe, feasible to im-
plement, could be taught and practiced by the children or the
parents independently, was practiced individually or as a
group, and whether it was a facilitator for conventional treat-
ment. Based on the recommendations and decisions that were
reached in the expert meeting and on the results from the
earlier phases, three text writers (representing the patient,
CAM, and scientific perspective) wrote the content for the
decision aid. The concept structure of the decision aid was
developed by members of the project team in parallel with
technical support from KSMT design (The Hague, the
Netherlands).
Phase 4: evaluation of decision aid
The content and structure of the decision aid were evaluated
through interviews and a short questionnaire (see

































Fig. 1 Project overview
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oncologists, and 13 parents. Evaluation was based on the look
and feel, structure, ease of comprehension, usability, naviga-
tion, usefulness in decision-making, and interface. Analysis of
feedback was performed by one researcher and the content
was adapted accordingly.
Results
Phase 1: needs of parents
In order to develop a practical and useful decision aid on
CAM use that is likely to be adopted by families affected by
cancer, the project started with investigation of the needs of
the parents.
Survey Among those surveyed, 70 parents responded.
Mothers made up the majority of respondents (93%).
Among all respondents, most had a child with leukemia
(55%) or a brain tumor (17%). Among the cancer-affected
children of respondents, 31% were currently in treatment
and 38% had finished treatment more than 1 year ago. More
than half (56%) reported CAM use for their child. Among
those who reported CAM, the use of food supplements/
vitamins (32%), massage (22%), and homeopathy (22%) were
most mentioned. One-third of those using CAM for their child
had searched for information about the CAM treatment before
use. Sources included the Internet (37%), family/friends
(37%), and CAM practitioners (26%). Eighty-eight percent
of respondents thought it was important to receive/find good
quality information on CAM. Most respondents (79%) had a
need for information on CAM following their child’s cancer
diagnosis, including 38% just after diagnosis, 45% during the
first year after cancer treatment, 34%more than a year follow-
ing cancer treatment, and 14% in the palliative phase. Parents
sought information on CAM for treatment of fatigue (62%),
anxiety (47%), pain (46%), weakened immune system (44%),
sleeping problems (42%), nausea/vomiting (35%), low mood
(29%), decreased appetite (27%), intestinal problems (22%),
concentration problems (16%), and weight loss (11%).
Parents mentioned a need for a decision aid to support their
discussions of CAM treatments with their physician (60%), to
find reliable CAM practitioners (59%), for education regard-
ing possible CAM use (45%), for support in asking questions
of CAM experts (43%), and as a resource for reading about
other parents’ experiences with CAM (40%). Preferences for
the form of the decision aid were website (62%), app (23%),
or informational brochure/leaflet (12%). Preference of most
respondents was that the decision aid be accessible via the
treating pediatric oncologist (88%) or VOKK (83%).
Focus group Direct content analysis was performed on five
themes: (1) Search strategies: Parents usually start searching
for CAM options after their child has been receiving treatment
for some time as closer to time of diagnosis they have too
much information to process. Parents report searching the
Internet for CAM modalities effective for specific complaints
or cancer types, for finding reliable CAM practitioners, and
for information on whether particular CAM modalities can be
combined with cancer treatment. (2) Decision-making:
Decisions on the use of CAM are mostly based on the positive
experiences of family/friends, on parent’s personal experi-
ences with CAM, or on the availability of evidence for a
particular CAM modality. (3) Format of the decision aid: A
website with a search function for complaint, type of cancer,
and CAMmodality, along with a chat function allowing inter-
action with other parents and a CAM expert who can answer
CAM-related questions. (4) Function of the decision aid: To
allow the parents make their own decisions with regard to
CAM, and also as a tool to discuss the outcome on CAMwith
the pediatric oncologist. (5) Content of the decision aid:
Description of positive effects of particular CAM modalities,
evidence for their use, potential side effects, and possible in-
terference with cancer treatment.
Phase 2: evidence on CAM
Based on the results of phase 1, the project team needed to
make a decision on the focus of the decision aid. Since there
are more than 1800 CAM modalities [24] and performing
systematic reviews to collect evidence-based information on
all these modalities is time-consuming, it was not feasible to
develop a decision aid on all childhood cancer-related com-
plaints for which parents in phase 1 wanted information about.
It was decided to focus on CAM use for pain during cancer
treatment and post-treatment because (1) pain was in the top
three complaints that parents wanted information about in
phase 1 and (2) the Dutch Childhood Oncology Group
(DCOG; www.skion.nl) was developing clinical guidelines
for treatment of pain, so a joint venture was planned.
Systematic review on CAM for pain Figure 2 shows the study
selection process. A total of 6936 records were identified from
searches, of which11 RCTs met the criteria for GRADE analysis
[25–35]. An additional 18 articles served as input for phase 3
(see online resource 5). The characteristics of the included RCTs
are summarized in Table 1. RCTs were found for five CAM
modalities: hypnotherapy (N = 5), massage (N = 3), healing
touch (N = 1), music therapy (N = 1), and mind-body interven-
tion (N = 1). Ten out of 11 studies investigated the changes in
pain related to procedures such as venapuncture, lumbar punc-
ture, or bonemarrow aspiration. The 11 studies included children
with all types of cancer. The quality of studies was moderate to
high for the RCTs on hypnotherapy and low to moderate for the
other CAM modalities (Table 1). Since the studies differed with
respect to pain scales, control groups, and number of RCTs per
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CAM modality, pooled effects on the primary outcome could
only be analyzed for hypnotherapy andmassage (Table 2). There
was high-quality evidence that hypnotherapy significantly re-
duces cancer-related procedural pain in children; the pooled ef-
fect was statistically significant (MD, − 1.37; 95% CI, − 1.60, −
1.15; P < 0.00001) compared with standard care [27–29], and
statistically significant (MD,− 1.13; 95%CI, − 1.34, − 0.94;P <
0.00001) compared with an attention-control group [26–29]
(Table 2). Both analyses showed significant heterogeneities
(P < 0.001), with I2 values of 87% in comparison with standard
care and 86% in comparison with attention-control. One high-
quality study on hypnotherapy by Smith et al. [34] was not
included in the meta-analysis because it used a different VAS
scale and outcome datawere only reported for childrenwith high
hypnotizability and children with low hypnotizability. There was
low-quality evidence for no effect of massage (Swedish/acupres-
sure and effleurage/petrissage techniques) on cancer-related pro-
cedural pain compared with standard care; the pooled effect of
two studies was not significantly different (MD, − 0.77; 95%CI,
− 1.82, 0.28; P = 0.15, heterogeneity I2 = 0%, P = 0.80)
(Table 2). No evidence was found that the five CAMmodalities
were unsafe to treat pain in children with cancer.
Since it is more challenging to conduct trials in children than
in adults [36], especially with regard to cancer, the number of
pediatric patients in studies is still limited [37]. Therefore, in
order to collect more information on the appropriate use of spe-
cific CAM modalities for pain management in children with
cancer, it was decided to investigate the clinical experiences of
pediatric oncologists with expertise in CAM. Experts had posi-
tive clinical experience with all five CAM modalities that were
found in the systematic review (see online resource 6).
Phase 3: development decision aid
Data of the systematic review and the clinical experience from
pediatric oncologist, as obtained in phase 2, formed the main
input for the development of the decision aid in phase 3. A
crucial step in phase 3 was to reach consensus among stake-
holders with respect to recommendations on CAM use. Five
CAM modalities (hypnotherapy, mind-body techniques, mas-
sage, healing touch, and music therapy) were included in the
decision aid based on the results from the systematic review. The
clinical expert opinions of pediatric oncologists in Integrative
Oncology as well as patients’ needs and preferences were con-
sidered important supplementary sources of information for
these five CAM modalities. Recommendations were given for
each CAM modality (see Table 3). The project team processed
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Fig. 2 Flow diagram of study
selection and identification
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meeting into a concept structure for a website-based decision
aid, and the content was written by three text writers.
Phase 4: evaluation and implementation of decision
aid
The content and structure of the decision aid as developed in
phase 3 was evaluated by the VOKK, parents, and pediatric
oncologists. Feedback included comments on the inclusion of
too much scientific terminology that some information was
too general in nature, to improve clarity with regard to which
CAMmodalities are supported by evidence and with regard to
the information on which the content was based. According to
the preference of parents (see “Phase 1: needs of parents”
under the “Results” section), the decision aid was linked to
the VOKK, the Dutch organization for parents of children
with cancer: http://www.complementairezorg-vokk.nl/.
The overall structure of the decision aid is depicted in Fig.
3. To facilitate its use, the VOKK announced the launch of the
decision aid via the newsletter, website, and Facebook page
and via an article in their printed newsmagazine. A “business”
card of the decision aid was developed for the Princess
Máxima Center for pediatric oncology, the recently
established high-complex care center for childhood cancer in
the Netherlands [38], to make parents aware of the existence
of the decision aid. Awareness among healthcare professionals
was created via DCOG, and the decision aid was introduced in
education programs at the Princess Máxima Center and at the
University Medical Center in Utrecht. The Louis Bolk
Institute assumed ownership and responsibility for mainte-
nance and updating of the decision aid.
Discussion
To the best of our knowledge, this is the first study that reports
on the development of an evidence-based decision aid for
supportive CAM care on pain in childhood cancer. The deci-
sion aid was primarily developed as a website for parents, but
is considered more than an information website. A decision
aid is defined as an evidence-based tool designed to help pa-
tients make specific and deliberate choices about available
healthcare options [39]. In order to facilitate patient-centered
decision-making, the totality of evidence in a decision aid
should comprise four pillars: research evidence, practice evi-
dence, patient evidence, and contextual factors [40]. First, the
decision aid provides evidence-based information. In addition
to high-quality research evidence, it incorporates information
from practice (clinical experience), contextual factors (feasi-
bility of implementation), and patient preferences. Second, it
is patient-centered and facilitates decision-making by parents
of children with cancer, for example helping them to decide
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Table 3 Recommendations on CAM use for pain management in children with cancer
CAM modality Evidence Recommendation Supplementary information
Hypnotherapy There is high-quality evidence
for a positive effect.
No evidence for side effects.
Hypnotherapy is recommended
for the prevention and/or
reduction of procedural pain.
For children of 6 years of age and older;
requires concentration and imagination; for
procedural and chronic pain, little to no side
effects; when the child experiences dizziness,
exercises can be performed when laying down;
can be guided by a hypnotherapist, a CD or
app with exercises or simple exercises can be
taught to the parent as to guide their child.
Mind-body
techniques
There is low-quality evidence
for an inconsistent effect.
No evidence for side effects
Mind-body techniques may be
considered for the prevention
and/or reduction of procedural
pain.
For children of 3–4 years of age and older;
mind-body techniques such as breathing and
relaxation techniques, meditation, and guided
imagery; for procedural pain and pain related
to stress and anxiety; supportive care option in
combination with physiotherapy; no reported
side effects; can be guided by trained nurse or
psychologist, a CD or app with exercises or
simple exercises can be taught to the parent as
to guide their child.
Massage There is low-quality evidence
for no effect.
No evidence for side effects
Massage is not recommended
for the prevention and/or
reduction of pain but may be
considered to support general
well-being.
For all ages; in each treatment phase; often
young children prefer to receive massage from
their parents; no reported side effects; massage
is contraindicated for open wounds and skin
lesions and low platelet counts; can be
provided by physiotherapist, nurse, or simple
exercises can be taught to the parent.
Healing touch There is low-quality evidence
for a positive effect.
Healing touch may be considered
for the prevention and/or
reduction of pain.
For all ages; in each treatment phase; specifically
suitable for children that do not like to be
touched; no reported side effects; may not
align with parents believes or religion; can
be provided by trained nurse, therapist or
parent can follow a course.
Music therapy There is low-quality evidence
for a positive effect.
Music therapy may be considered
for the prevention and/or
reduction of procedural pain.
For all ages; in each treatment phase; no
reported side effects; can be provided by
music therapist, a CD or app.
How to find a 
reliable CAM 
therapist
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Third, it supports parents to recognize possible benefits and
harm related to their decision about CAM use for their child.
Finally, the decision aid is designed to be helpful for parents in
discussions of CAM with healthcare professionals. Although
few parents currently discuss CAM use with the treating pe-
diatric oncologist [7, 12, 13], the majority want to receive
information and discuss it with them [7]. The use of the deci-
sion aid as a tool has the potential to improve communication
on CAM between parents and healthcare providers.
One of the major limitations of the current decision aid is that
it is limited to decision-making on CAM modalities for pain
relief. The potential effectiveness of the five CAM modalities
included in the decision aid, or of other CAM modalities in
addressing other complaints than pain, was not investigated.
Recently, a RCT in children undergoing hematopoietic stem cell
transplants reported that although music therapy did not signifi-
cantly reduce pain compared with control, it significantly en-
hanced health-related quality of life [41]. Another major limita-
tion of this study is that it did not evaluate whether the current
decision aid actually improved parents’ knowledge regarding
CAM treatment options, or whether it reduced the decisional
conflict stemming from feeling uninformed and unclear about
treatment options. Future studies are planned to evaluate the
effectiveness of the decision aid for parents in practice and, ad-
ditionally, to assess its use in communication between parents
and healthcare professionals. In the present study, parents wanted
information on CAM for a broad spectrum of symptoms related
to childhood cancer treatment, i.e., fatigue, anxiety, and pain.
This is in line with a previous study, demonstrating that parents
perceive high symptomburden in their childrenwith cancer, pain
being the most problematic area [42]. Next steps recommended
concern expanding the decision aid on CAM for other pediatric
cancer-related complaints, as to provide further evidence on how
CAMmodalities may contribute to reduce the symptom burden
in children with cancer. In addition, further investigations are
warranted as to disclose potential harmful interactions between
CAM remedies and cancer drugs.
A strength of the present study is that the decision aid was
developed based on the true needs of parents and was developed
by a multidisciplinary team who consider CAM worthy of seri-
ous evaluation, so that the perspectives and contextual factors of
stakeholders in childhood cancer were taken into account.
In conclusion, an evidence-based decision aid was developed
to support parents of children with cancer in making decisions on
possible CAM treatment for pain management. Next steps will
be to expand the website with evidence for CAM on other child-
hood cancer-related complaints and to evaluate its use in practice.
Acknowledgments First, we would like to thank Wouter Kollen,
Maroeska te Loo, Marc Bierings, Erna Michiels, Hubert Caron, and
Arine Vlieger for their scientific and clinical expertise and advice in the
different phases of the project. Suzanne van Roijen, Marja van Vliet, and
Winnie Schats are acknowledged for their support with the systematic
literature review and survey. We are grateful to Erik Loeffen, Lidwien
Daniels, Evelien Otto, Martine van Grotel, Christel Suiker, Juul
Coumans, Marie Jose Griffioen, Jacky Gore, and Kees van de Ven for their
valuable input and critical feedback. Lastly, we thank Megan Voss, Kara
Kelly, Georg J. Seifert, Alfred Längler, Hsing Jou, and Emanuela Portalupi
for sharing their clinical experiences with integrative pediatric oncology.
Funding information Open access funding provided by Mid Sweden
University. This work was supported by grants from the Foundation Nuts
Ohra (grant no. 1404-021) and the Signe and Ane Gyllenberg Foundation.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
Ethical approval This project did not involve experiments with patients or
study subjects according to the Dutch Medical Research Involving Human
Subjects Act (WMO) and was therefore exempt from ethical approval.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. Trafalska E, Grzybowska K (2004) Probiotics–an alternative for antibi-
otics? Wiadomosci lekarskie (Warsaw, Poland : 1960) 57(9–10):491–
498
2. Ladas E,Marjerrison S, Arora B, Hesseling P, Ortiz R, Antillon F, Jatia
S, Afungchwi G (2017) Traditional and complementary medicine in
pediatric oncology and low-middle income countries: recommenda-
tions from the International Society of Pediatric Oncology (SIOP),
T&CM collaborative. 2017. https://doi.org/10.1093/jncimonographs/
lgx014
3. Diorio C, Lam CG, Ladas EJ, Njuguna F, Afungchwi GM, Taromina
K, Marjerrison S (2016) Global use of traditional and complementary
medicine in childhood cancer: a systematic review. J Glob Oncol 3(6):
791–800. https://doi.org/10.1200/JGO.2016.005587
4. Bishop FL, Prescott P, Chan YK, Saville J, von Elm E, Lewith GT
(2010) Prevalence of complementary medicine use in pediatric can-
cer: a systematic review. Pediatrics 125(4):768–776. https://doi.org/
10.1542/peds.2009-1775
5. Post-White J, Fitzgerald M, Hageness S, Sencer SF (2009)
Complementary and alternative medicine use in children with can-
cer and general and specialty pediatrics. J Pediatr Oncol Nurs 26(1):
7–15. https://doi.org/10.1177/1043454208323914
6. Magi T, Kuehni CE, Torchetti L,Wengenroth L, Luer S, Frei-ErbM
(2015) Use of complementary and alternative medicine in children
with cancer: a study at a Swiss university hospital. PLoS One
10(12):e0145787. https://doi.org/10.1371/journal.pone.0145787
7. Singendonk M, Kaspers GJ, Naafs-Wilstra M, Meeteren AS,
Loeffen J, Vlieger A (2013) High prevalence of complementary
and alternative medicine use in the Dutch pediatric oncology pop-
ulation: a multicenter survey. Eur J Pediatr 172(1):31–37. https://
doi.org/10.1007/s00431-012-1821-6
8. National Cancer Institute. Complementary and Alternative
Medicine for Patients. (2019). https://www.cancer.gov/about-
cancer/treatment/cam/patient. Accessed 11 June 2019
Support Care Cancer (2020) 28:2415–24292428
9. Hargrave DR, Hargrave UA, Bouffet E (2006) Quality of health infor-
mation on the Internet in pediatric neuro-oncology. Neuro-Oncology
8(2):175–182. https://doi.org/10.1215/15228517-2005-008
10. Roth M, Lin J, Kim M, Moody K (2009) Pediatric oncologists’
views toward the use of complementary and alternative medicine
in children with cancer. J Pediatr Hematol Oncol 31(3):177–182.
https://doi.org/10.1097/MPH.0b013e3181984f5a
11. Vlieger AM, van Vliet M, Jong MC (2011) Attitudes toward com-
plementary and alternative medicine: a national survey among pae-
diatricians in the Netherlands. Eur J Pediatr 170(5):619–624.
https://doi.org/10.1007/s00431-010-1331-3
12. Gomez-Martinez R, Tlacuilo-Parra A, Garibaldi-Covarrubias R
(2007) Use of complementary and alternative medicine in children
with cancer in Occidental, Mexico. Pediatr Blood Cancer 49(6):
820–823. https://doi.org/10.1002/pbc.21101
13. Turhan AB, Bor O (2016) Use of herbs or vitamin/mineral/nutrient
supplements by pediatric oncology patients. Complement Ther Clin
Pract 23:69–74. https://doi.org/10.1016/j.ctcp.2016.03.009
14. Kelly KM (2004) Complementary and alternative medical therapies
for children with cancer. Eur J Cancer 40(14):2041–2046. https://
doi.org/10.1016/j.ejca.2004.05.012
15. Ladas EJ (2018) Integrative medicine in childhood cancer. J Altern
Complement Med 24(9–10):910–915. https://doi.org/10.1089/acm.
2018.0224
16. Broerse J, Breukers W, Elberse J, Branje D (2012)
Patientenparticipatie bij de ontwikkeling van een individueel
zorgplan voor mensen met COPD. Athena Instituut
17. JongMC, van de Vijver L, BuschM, Fritsma J, Seldenrijk R (2012)
Integration of complementary and alternative medicine in primary
care: what do patients want? Patient Educ Couns 89(3):417–422.
https://doi.org/10.1016/j.pec.2012.08.013
18. Paulus PB, Yang H-C (2000) Idea generation in groups: a basis for
creativity in organizations. Organ Behav Hum Decis Process 82(1):
76–87. https://doi.org/10.1006/obhd.2000.2888
19. Hsieh H-F, Shannon SE (2005) Three approaches to qualitative
content analysis. Qual Health Res 15(9):1277–1288. https://doi.
org/10.1177/1049732305276687
20. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M,
Shekelle P, Stewart LA (2015) Preferred reporting items for systematic
review andmeta-analysis protocols (PRISMA-P) 2015: elaboration and
explanation. BMJ 349:g7647. https://doi.org/10.1136/bmj.g7647
21. Stone JA, Yoder KK, Case EA (2009) Delivery of a full-term preg-
nancy after TCM treatment in a previously infertile patient diag-
nosed with polycystic ovary syndrome. Altern Ther Health Med
15(1):50–52
22. Schünemann H, Brożek J, Guyatt G, Oxman A (2013) Handbook
for grading the quality of evidence and the strength of recommen-
dations using the GRADE approach. Updated October 2013. The
GRADE Working Group, 2013. Available from: www.
guidelinedevelopment.org/handbook
23. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-
Coello P, Schunemann HJ (2008) GRADE: an emerging consensus
on rating quality of evidence and strength of recommendations. BMJ
336(7650):924–926. https://doi.org/10.1136/bmj.39489.470347.AD
24. Kramlich D (2014) Introduction to complementary, alternative, and
traditional therapies. Crit Care Nurse 34(6):50–56; quiz 57. https://
doi.org/10.4037/ccn2014807
25. Celebioglu A, Gurol A, Yildirim ZK, Buyukavci M (2015) Effects
of massage therapy on pain and anxiety arising from intrathecal
therapy or bone marrow aspiration in children with cancer. Int J
Nurs Pract 21(6):797–804. https://doi.org/10.1111/ijn.12298
26. Katz ER, Kellerman J, Ellenberg L (1987) Hypnosis in the reduc-
tion of acute pain and distress in children with cancer. J Pediatr
Psychol 12(3):379–394. https://doi.org/10.1093/jpepsy/12.3.379
27. Liossi C, Hatira P (2003) Clinical hypnosis in the alleviation of
procedure-related pain in pediatric oncology patients. Int J Clin
Exp Hypn 51(1):4–28. https://doi.org/10.1076/iceh.51.1.4.14064
28. Liossi C, White P, Hatira P (2006) Randomized clinical trial of local
anesthetic versus a combination of local anestheticwith self-hypnosis in
the management of pediatric procedure-related pain. Health Psychol
25(3):307–315. https://doi.org/10.1037/0278-6133.25.3.307
29. Liossi C, White P, Hatira P (2009) A randomized clinical trial of a
brief hypnosis intervention to control venepuncture-related pain of
paediatric cancer patients. Pain 142(3):255–263. https://doi.org/10.
1016/j.pain.2009.01.017
30. Mehling WE, Lown EA, Dvorak CC, Cowan MJ, Horn BN, Dunn
EA, Acree M, Abrams DI, Hecht FM (2012) Hematopoietic cell
transplant and use of massage for improved symptommanagement:
results from a pilot randomized control trial. Evid Based
Complement Alternat Med 2012:450150–450159. https://doi.org/
10.1155/2012/450150
31. Nguyen TN, Nilsson S, Hellström A-L, Bengtson A (2010) Music
therapy to reduce pain and anxiety in children with cancer under-
going lumbar puncture: a randomized clinical trial. J Pediatr Oncol
Nurs 27(3):146–155. https://doi.org/10.1177/1043454209355983
32. Phipps S, Dunavant M, Gray E, Rai S (2005) Massage therapy in
children undergoing hematopoietic stem cell transplantation: results
of a pilot trial. J Cancer Integr Med 3:62–70
33. Pourmovahed Z, Dehghani K, Sherafat A (2013) Effectiveness of
regular breathing technique (hey-hu) on reduction of intrathecal
injection pain in leukemic children: a randomized clinical trial.
Iran J Pediatr 23:564–568
34. Smith JT, Barabasz A, Barabasz M (1996) Comparison of hypnosis
and distraction in severely ill children undergoing painful medical
procedures. J Couns Psychol 43(2):187–195. https://doi.org/10.
1037/0022-0167.43.2.187
35. Wong J, Ghiasuddin A, Kimata C, Patelesio B, Siu A (2013) The
impact of healing touch on pediatric oncology patients. Integr Cancer
Ther 12(1):25–30. https://doi.org/10.1177/1534735412446864
36. Joseph PD, Craig JC, Caldwell PHY (2015) Clinical trials in children.
Br J Clin Pharmacol 79(3):357–369. https://doi.org/10.1111/bcp.12305
37. BondMC, Pritchard S (2006) Understanding clinical trials in child-
hood cancer. Paediatr Child Health 11(3):148–150
38. Narcis (2018) Princess Máxima Center for pediatric oncology Data
Archiving and Networked Services (DANS), KNAW and NWO.
https://www.narcis.nl/organisation/RecordID/ORG1244187/
Language/en. Accessed 26 March 2019
39. Stacey D, Légaré F, Lewis K, Barry MJ, Bennett CL, Eden KB,
Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R,
Trevena L, Cochrane Consumers and Communication Group
(2017) Decision aids for people facing health treatment or screening
decisions. Cochrane Database Syst Rev 4. https://doi.org/10.1002/
14651858.CD001431.pub5
40. Clifford AM, Ryan J, Walsh C, McCurtin A (2017) What information
is used in treatment decision aids? A systematic review of the types of
evidence populating health decision aids. BMC Med Inform Decis
Mak 17(1):22–22. https://doi.org/10.1186/s12911-017-0415-7
41. Uggla L, Bonde LO, Hammar U,Wrangsjo B, Gustafsson B (2018)
Music therapy supported the health-related quality of life for chil-
dren undergoing haematopoietic stem cell transplants. Acta
Paediatr 107(11):1986–1994. https://doi.org/10.1111/apa.14515
42. Pöder U, Ljungman G, von Essen L (2010) Parents’ perceptions of
their children’s cancer-related symptoms during treatment: a pro-
spective, longitudinal study. J Pain Symptom Manag 40(5):661–
670. https://doi.org/10.1016/j.jpainsymman.2010.02.012
Publisher’s note Springer Nature remains neutral with regard to juris-
dictional claims in published maps and institutional affiliations.
Support Care Cancer (2020) 28:2415–2429 2429
